Consolidated Statement of Changes in Shareholders’ Equity (Unaudited) - 3 months ended Mar. 31, 2023 - USD ($)	Total	Additional paid-in-capital	Retained earnings (accumulated deficit)	Accumulated other comprehensive income	Non-controlling interest in subsidiaries	Total Members' Capital	Class A shares	Class A shares Common Stock	Class B shares	Class B shares Common Stock
Beginning balance (in shares) at Jan. 02, 2023								55,388,023		55,032,961
Beginning balance at Jan. 02, 2023	$ 1,014,908,000	$ 435,859,000	$ (27,946,000)	$ 0	$ 606,989,000			$ 6,000		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Shares to Alvarium Trust								2,100,000
Issuance of shares to Alvarium Employee Benefit Trust	21,000,000	21,000,000
Net income (loss)	(90,290,000)		(68,740,000)		(21,550,000)
Currency translation adjustment	9,671,000			4,941,000	4,730,000
Issuance of shares - exercise of warrants (in shares)							428,626	428,626
Issuance of shares - exercise of warrants	5,416,000	5,416,000
Ending balance (in shares) at Mar. 31, 2023							57,916,649	57,916,649	55,032,961	55,032,961
Ending balance at Mar. 31, 2023	960,705,000	$ 462,275,000	$ (96,686,000)	4,941,000	590,169,000			$ 6,000		$ 0
Beginning balance at Jan. 02, 2023	$ 40,021,000			$ 0	$ 433,000	$ 39,588,000		$ 6,000		$ 39,582,000